Global medical technology company, Getinge, has agreed to acquire FLUOPTICS, a French based developer of fluorescence imaging as an aid to surgery. The transaction, made through its subsidiary Getinge Infection Control, will expand Getinge’s customer offering in clinical decision support. The cash acquisition of all outstanding shares of FLUOPTICS will cost. approximately €26m (US$27.4m) on closing….
You must be a HMI Subscriber to view this content.